3-[1-[2-[(4S)-2,2-dimethyloxan-4-yl]-6-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methylspiro[4,6-dihydropyrazolo[4,3-c]pyridine-7,1'-cyclopropane]-5-carbonyl]pyrrolo[1,2-b]pyridazin-5-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one

C48H47F2N11O5 — CID 176798081

IUPAC3-[1-[2-[(4S)-2,2-dimethyloxan-4-yl]-6-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methylspiro[4,6-dihydropyrazolo[4,3-c]pyridine-7,1'-cyclopropane]-5-carbonyl]pyrrolo[1,2-b]pyridazin-5-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one
SMILESCc1cc(-n2nc3c(c2-n2ccn(-c4ccc5c(cnn5C)c4F)c2=O)[C@H](C)N(C(=O)c2cn4nc([C@H]5CCOC(C)(C)C5)ccc4c2C2(c4noc(=O)[nH]4)CC2)CC32CC2)cc(C)c1F
InChIInChI=1S/C48H47F2N11O5/c1-25-19-29(20-26(2)38(25)49)61-41(58-17-16-57(45(58)64)35-10-9-33-30(39(35)50)22-51-56(33)6)36-27(3)59(24-47(12-13-47)40(36)54-61)42(62)31-23-60-34(37(31)48(14-15-48)43-52-44(63)66-55-43)8-7-32(53-60)28-11-18-65-46(4,5)21-28/h7-10,16-17,19-20,22-23,27-28H,11-15,18,21,24H2,1-6H3,(H,52,55,63)/t27-,28-/m0/s1
InChIKeyLYAPRAGOJORNBX-NSOVKSMOSA-N
MW895.97 g/mol
LogP6.92
Rot. Bonds7

About 3-[1-[2-[(4S)-2,2-dimethyloxan-4-yl]-6-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methylspiro[4,6-dihydropyrazolo[4,3-c]pyridine-7,1'-cyclopropane]-5-carbonyl]pyrrolo[1,2-b]pyridazin-5-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one

3-[1-[2-[(4S)-2,2-dimethyloxan-4-yl]-6-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methylspiro[4,6-dihydropyrazolo[4,3-c]pyridine-7,1'-cyclopropane]-5-carbonyl]pyrrolo[1,2-b]pyridazin-5-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one (PubChem CID 176798081) has the molecular formula C48H47F2N11O5 and a molecular weight of 895.97 g/mol. Its IUPAC name is 3-[1-[2-[(4S)-2,2-dimethyloxan-4-yl]-6-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methylspiro[4,6-dihydropyrazolo[4,3-c]pyridine-7,1'-cyclopropane]-5-carbonyl]pyrrolo[1,2-b]pyridazin-5-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one.

Molecular Properties

Compound Name3-[1-[2-[(4S)-2,2-dimethyloxan-4-yl]-6-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methylspiro[4,6-dihydropyrazolo[4,3-c]pyridine-7,1'-cyclopropane]-5-carbonyl]pyrrolo[1,2-b]pyridazin-5-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one
PubChem CID176798081
Molecular FormulaC48H47F2N11O5
Molecular Weight895.97 g/mol
Exact Mass895.37
IUPAC Name3-[1-[2-[(4S)-2,2-dimethyloxan-4-yl]-6-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methylspiro[4,6-dihydropyrazolo[4,3-c]pyridine-7,1'-cyclopropane]-5-carbonyl]pyrrolo[1,2-b]pyridazin-5-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one
SMILESCc1cc(-n2nc3c(c2-n2ccn(-c4ccc5c(cnn5C)c4F)c2=O)[C@H](C)N(C(=O)c2cn4nc([C@H]5CCOC(C)(C)C5)ccc4c2C2(c4noc(=O)[nH]4)CC2)CC32CC2)cc(C)c1F
InChIInChI=1S/C48H47F2N11O5/c1-25-19-29(20-26(2)38(25)49)61-41(58-17-16-57(45(58)64)35-10-9-33-30(39(35)50)22-51-56(33)6)36-27(3)59(24-47(12-13-47)40(36)54-61)42(62)31-23-60-34(37(31)48(14-15-48)43-52-44(63)66-55-43)8-7-32(53-60)28-11-18-65-46(4,5)21-28/h7-10,16-17,19-20,22-23,27-28H,11-15,18,21,24H2,1-6H3,(H,52,55,63)/t27-,28-/m0/s1
InChIKeyLYAPRAGOJORNBX-NSOVKSMOSA-N
XLogP6.92
TPSA168.30 Ų
H-Bond Donors1
H-Bond Acceptors14
Rotatable Bonds7
Heavy Atoms66
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500895.97
LogP ≤ 56.92
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1014

Analyze 3-[1-[2-[(4S)-2,2-dimethyloxan-4-yl]-6-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methylspiro[4,6-dihydropyrazolo[4,3-c]pyridine-7,1'-cyclopropane]-5-carbonyl]pyrrolo[1,2-b]pyridazin-5-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[1-[2-[(4S)-2,2-dimethyloxan-4-yl]-6-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methylspiro[4,6-dihydropyrazolo[4,3-c]pyridine-7,1'-cyclopropane]-5-carbonyl]pyrrolo[1,2-b]pyridazin-5-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one?
The IUPAC name of 3-[1-[2-[(4S)-2,2-dimethyloxan-4-yl]-6-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methylspiro[4,6-dihydropyrazolo[4,3-c]pyridine-7,1'-cyclopropane]-5-carbonyl]pyrrolo[1,2-b]pyridazin-5-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one (CID 176798081) is 3-[1-[2-[(4S)-2,2-dimethyloxan-4-yl]-6-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methylspiro[4,6-dihydropyrazolo[4,3-c]pyridine-7,1'-cyclopropane]-5-carbonyl]pyrrolo[1,2-b]pyridazin-5-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one.
What is the SMILES notation for 3-[1-[2-[(4S)-2,2-dimethyloxan-4-yl]-6-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methylspiro[4,6-dihydropyrazolo[4,3-c]pyridine-7,1'-cyclopropane]-5-carbonyl]pyrrolo[1,2-b]pyridazin-5-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one?
The canonical SMILES for 3-[1-[2-[(4S)-2,2-dimethyloxan-4-yl]-6-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methylspiro[4,6-dihydropyrazolo[4,3-c]pyridine-7,1'-cyclopropane]-5-carbonyl]pyrrolo[1,2-b]pyridazin-5-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one is Cc1cc(-n2nc3c(c2-n2ccn(-c4ccc5c(cnn5C)c4F)c2=O)[C@H](C)N(C(=O)c2cn4nc([C@H]5CCOC(C)(C)C5)ccc4c2C2(c4noc(=O)[nH]4)CC2)CC32CC2)cc(C)c1F.
What is the InChIKey of 3-[1-[2-[(4S)-2,2-dimethyloxan-4-yl]-6-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methylspiro[4,6-dihydropyrazolo[4,3-c]pyridine-7,1'-cyclopropane]-5-carbonyl]pyrrolo[1,2-b]pyridazin-5-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one?
The InChIKey is LYAPRAGOJORNBX-NSOVKSMOSA-N. The full InChI is InChI=1S/C48H47F2N11O5/c1-25-19-29(20-26(2)38(25)49)61-41(58-17-16-57(45(58)64)35-10-9-33-30(39(35)50)22-51-56(33)6)36-27(3)59(24-47(12-13-47)40(36)54-61)42(62)31-23-60-34(37(31)48(14-15-48)43-52-44(63)66-55-43)8-7-32(53-60)28-11-18-65-46(4,5)21-28/h7-10,16-17,19-20,22-23,27-28H,11-15,18,21,24H2,1-6H3,(H,52,55,63)/t27-,28-/m0/s1.
What are the key properties of 3-[1-[2-[(4S)-2,2-dimethyloxan-4-yl]-6-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methylspiro[4,6-dihydropyrazolo[4,3-c]pyridine-7,1'-cyclopropane]-5-carbonyl]pyrrolo[1,2-b]pyridazin-5-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one?
3-[1-[2-[(4S)-2,2-dimethyloxan-4-yl]-6-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methylspiro[4,6-dihydropyrazolo[4,3-c]pyridine-7,1'-cyclopropane]-5-carbonyl]pyrrolo[1,2-b]pyridazin-5-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one has a molecular weight of 895.97 g/mol, XLogP of 6.92, 7 rotatable bonds, 1 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[1-[2-[(4S)-2,2-dimethyloxan-4-yl]-6-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methylspiro[4,6-dihydropyrazolo[4,3-c]pyridine-7,1'-cyclopropane]-5-carbonyl]pyrrolo[1,2-b]pyridazin-5-yl]cyclopropyl]-4H-1,2,4-oxadiazol-5-one is sourced from PubChem (CID 176798081), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).